| 3 |
Wang ZP，Wang L，Wang S，et al.Burden of kidney cancer and attributed risk factors in China from 1990 to 2019 ［J］. Front Public Health，2022，10：1062504.
|
| 4 |
Charvat H，Nakata KY.Projection of the number of new cases of kidney and renal pelvis cancer in the world ［J］. Jpn J Clin Oncol， 2023，53（11）：1096-1097.
|
| 5 |
Dabestani S， Thorstenson A， Lindblad P， et al. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients：a population-based study［J］.World J Urol，2016，34（8）：1081-1086.
|
| 6 |
Lei M， Miao J. Factors affecting survival and prognosis in surgically treated patients with spinal metastases arising from renal cell carcinoma［J］.BMC Urol，2023，23（1）：118.
|
| 7 |
Woodward E， Jagdev S， McParland L， et al. Skeletal complications and survival in renal cancer patients with bone metastases ［J］. Bone，2011，48（1）：160-166.
|
| 8 |
Luksanapruksa P， Buchowski JM，Tongsai SSA， et al. Systematic review and meta-analysis of effectiveness of preoperative embolization in surgery for metastatic spine disease ［J］. J Neurointerv Surg， 2018，10（6）：596-601.
|
| 9 |
Kato S， Demura S， Shinmura K， et al. Surgical metastasectomy in the spine： a review article ［J］. Oncologist， 2021， 26（10）： e1833-e1843.
|
| 10 |
Fehlings MG， Nater A， Tetreault L， et al. Survival and clinical outcomes in surgically treated patients with metastatic epidural spinal cord compression： results of the prospective multicenter AOSpine study［J］.J Clin Oncol，2016，34（3）：268-276.
|
| 11 |
Rothrock RJ， Barzilai O， Reiner AS， et al. Survival trends after surgery for spinal metastatic tumors： 20-Year cancer center experience［J］.Neurosurgery，2021，88（2）：402-412.
|
| 12 |
Xiong GX， Fisher MWA， Schwab JH， et al.A natural history of patients treated operatively and nonoperatively for spinal metastases over 2 years following treatment： survival and functional outcomes［J］.Spine（Phila Pa 1976），2022，47（7）：515-522.
|
| 13 |
Thirunavu VM，Roumeliotis A，Shlobin NA，et al.The role of preoperative embolization in the treatment of spinal metastases from renal cell carcinoma［J］.Clin Neurol Neurosurg，2022，215：107181.
|
| 14 |
Lee JH， Linzey JR， Strong MJ， et al. Local control in patients with metastatic renal cell carcinoma to the spine： the experience of an institution with a multidisciplinary spine oncology program ［J］. World Neurosurg，2023，178：e403-e409.
|
| 15 |
Pennington Z， Pairojboriboon S， Chen XG， et al. Utility of expanded anterior column resection versus decompression-alone for local control in the management of carcinomatous vertebral column metastases undergoing adjuvant stereotactic radiotherapy ［J］. Spine J， 2022，22（5）：835-846.
|
| 16 |
万丽， 赵晴， 陈军， 等. 疼痛评估量表应用的中国专家共识（2020版）［J］.中华疼痛学杂志，2020，16（3）：177-187.
|
| 17 |
Frankel HL， Hancock DO， Hyslop G， et al.The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia.I［J］.Paraplegia，1969，7（3）：179-192.
|
| 18 |
Karnofsky DA，Abelmann WH，Craver LF，et al.The use of the Nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma［J］.Cancer，1948，1（4）：634-656.
|
| 19 |
Tokuhashi Y， Matsuzaki H， Oda H， et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis ［J］.Spine（Phila Pa 1976），2005，30（19）：2186-2191.
|
| 20 |
King GJ， Kostuik JP， McBroom RJ， et al. Surgical management of metastatic renal carcinoma of the spine ［J］. Spine （Phila Pa 1976），1991，16（3）：265-271.
|
| 21 |
Jackson RJ， Loh SC， Gokaslan ZL. Metastatic renal cell carcinoma of the spine：surgical treatment and results ［J］. J Neurosurg， 2001， 94（1 Suppl）：18-24.
|
| 22 |
Bakker NA，Coppes MH，Vergeer RA，et al.Surgery on spinal epidural metastases （SEM） in renal cell carcinoma： a plea for a new paradigm［J］.Spine J，2014，14（9）：2038-2041.
|
| 23 |
Tatsui CE， Suki D， Rao G， et al. Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma［J］.J Neurosurg Spine，2014，20（1）：108-116.
|
| 24 |
Han S，Wang T，Jiang DJ，et al.Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases［J］.Eur Spine J，2015，24（8）：1786-1791.
|
| 25 |
Kato S， Murakami H， Demura S， et al. Spinal metastasectomy of renal cell carcinoma： A 16-year single center experience with a minimum 3-year follow-up［J］.J Surg Oncol，2016，113（5）：587-592.
|
| 26 |
Petteys RJ，Spitz SM，Goodwin CR，et al.Factors associated with improved survival following surgery for renal cell carcinoma spinal metastases［J］.Neurosurg Focus，2016，41（2）：E13.
|
| 27 |
Mosele GR，Caggiari G，Scarpa RM，et al.The treatment of vertebral metastases from renal cell carcinoma：a retrospective study［J］.Minerva Urol Nefrol，2017，69（2）：166-172.
|
| 28 |
Ptashnikov D， Zaborovskii N， Kostrickii S， et al. Metastasectomy and targeted therapy for patients with spinal metastases of renal cell carcinoma ［J］. International Journal of Spine Surgery， 2020， 14（6）：982-988.
|
| 29 |
Shankar GM，Van Beaver LA， Choi BD， et al. Survival after surgery for renal cell carcinoma metastatic to the spine： impact of modern systemic therapies on outcomes［J］.Neurosurgery，2020，87（6）：1174-1180.
|
| 30 |
Kato S， Demura S， Murakami H， et al. Clinical outcomes and prognostic factors following the surgical resection of renal cell carcinoma spinal metastases［J］.Cancer Sci，2021，112（6）：2416-2425.
|
| 1 |
Zheng BS， Wang SD， Zhang JY， et al. Incidence， prognostic factors，and survival of patients with renal cancer： a Population-Based study［J］.J Invest Surg，2023，36（1）：2197506.
|
| 2 |
Motzer RJ，Jonasch E，Boyle S，et al.NCCN guidelines insights：kidney cancer， version 1.2021 ［J］. J Natl Compr Canc Netw， 2020， 18（9）：1160-1170.
|
| 31 |
Park BJ， Seaman SC， Noeller JL， et al. Metastatic renal cell carcinoma to the spine： outcomes and morbidity： Single-Center experience［J］.World Neurosurg，2021，154：e398-e405.
|
| 32 |
Zhai JP， Liu N， Wang H， et al. Clinical characteristics and prognosis of renal cell carcinoma with spinal bone metastases ［J］. Front Oncol，2021，11：659779.
|
| 33 |
Terzi S， Pipola V， Griffoni C， et al. Clear cell renal cell carcinoma spinal metastases： which factors matter to the overall survival？ a 10-Year experience of a High-Volume tumor spine center ［J］. DIAGNOSTICS，2022，12（10）：2442.
|
| 34 |
Ito K，Sugita S，Nakajima Y，et al.Phase 2 clinical trial of separation surgery followed by stereotactic body radiation therapy for metastatic epidural spinal cord compression［J］.Int J Radiat Oncol Biol Phys，2022，112（1）：106-113.
|
| 35 |
Li RF，Qiao RQ，Xu MY，et al.Separation surgery in the treatment of spinal metastasis ［J］. Technol Cancer Res Treat， 2022， 21：15330338221107208.
|
| 36 |
Hussain I，Goldberg JL，Carnevale JA，et al.Hybrid therapy（surgery and radiosurgery）for the treatment of renal cell carcinoma spinal metastases［J］.Neurosurgery，2022，90（2）：199-206.
|
| 37 |
Ruatta F，Derosa L，Escudier B，et al.Prognosis of renal cell carcinoma with bone metastases： Experience from a large cancer centre ［J］.Eur J Cancer，2019，107：79-85.
|
| 38 |
Du YJ， Pahernik S， Hadaschik B， et al. Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy： A single-institution analysis ［J］. Urol Oncol，2016，34（10）：433.e1-433.e8.
|
| 39 |
Shinohara N，Nonomura K，Abe T，et al.A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma ［J］. Cancer Sci， 2012， 103（9）： 1695-1700.
|
| 40 |
Langerhuizen DWG， Janssen SJ， van der Vliet QMJ， et al. Metastasectomy， intralesional resection， or stabilization only in the treatment of bone metastases from renal cell carcinoma ［J］. J Surg Oncol，2016，114（2）：237-245.
|